JUNS vs ZBH · rev $21.8K vs P/E 23, rev $4.26B
Jupiter Neurosciences, Inc. Common Stock (JUNS) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
JUNS currently screens at market cap $10.0M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the JUNS and ZBH stock pages for the full models.
Not investment advice.